Lacosamide Patent Expiration

Lacosamide is Used for treating partial-onset seizures in patients with epilepsy aged 17 years and older, either as adjunctive therapy or when oral treatment is temporarily not feasible. It was first introduced by Ucb Inc in its drug Vimpat on Oct 28, 2008. Another drug containing Lacosamide is Motpoly Xr. 30 different companies have introduced drugs containing Lacosamide.


Lacosamide Patents

Given below is the list of patents protecting Lacosamide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Motpoly Xr US11337943 Lacosamide pharmaceutical composition and dosage form thereof Jun 05, 2040 Aucta
Vimpat US5654301 Amino acid derivative anticonvulsant Aug 05, 2014

(Expired)

Ucb Inc
Vimpat USRE38551 Anticonvulsant enantiomeric amino acid derivatives Mar 17, 2022

(Expired)

Ucb Inc


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Lacosamide Generics

Several generic applications have been filed for Lacosamide. The first generic version for Lacosamide was by Mylan Pharmaceuticals Inc and was approved on Apr 28, 2016. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on May 24, 2024.

Given below is the list of companies who have filed for Lacosamide generic.


1. ASPIRO

Aspiro Pharma Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Aspiro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML) solution Prescription INTRAVENOUS AP Sep 14, 2022


2. HETERO LABS LTD III

Hetero Labs Ltd Unit Iii has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML solution Prescription ORAL AA May 31, 2022


3. AMNEAL PHARMS

Amneal Pharmaceuticals has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG tablet Prescription ORAL AB Mar 17, 2022
200MG tablet Prescription ORAL AB Mar 17, 2022
50MG tablet Prescription ORAL AB Mar 17, 2022
100MG tablet Prescription ORAL AB Mar 17, 2022
10MG/ML solution Discontinued ORAL N/A Mar 27, 2024


4. MSN

Msn Laboratories Private Ltd has filed for 2 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Msn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML) solution Prescription INTRAVENOUS AP Feb 9, 2023
10MG/ML solution Prescription ORAL AA Dec 22, 2023


5. APOTEX

Apotex Inc has filed for 6 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG tablet Discontinued ORAL N/A Sep 23, 2022
100MG tablet Discontinued ORAL N/A Sep 23, 2022
150MG tablet Discontinued ORAL N/A Sep 23, 2022
200MG tablet Discontinued ORAL N/A Sep 23, 2022
10MG/ML solution Prescription ORAL AA Sep 26, 2022
200MG/20ML (10MG/ML) solution Prescription INTRAVENOUS AP Nov 13, 2023


6. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG tablet Prescription ORAL AB Mar 17, 2022
100MG tablet Prescription ORAL AB Mar 17, 2022
150MG tablet Prescription ORAL AB Mar 17, 2022
200MG tablet Prescription ORAL AB Mar 17, 2022


7. MSN LABS PVT LTD

Msn Laboratories Private Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Msn Labs Pvt Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG tablet Prescription ORAL AB Mar 17, 2022
100MG tablet Prescription ORAL AB Mar 17, 2022
150MG tablet Prescription ORAL AB Mar 17, 2022
200MG tablet Prescription ORAL AB Mar 17, 2022


8. GLAND PHARMA LTD

Gland Pharma Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML) solution Prescription INTRAVENOUS AP Sep 19, 2022


9. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML) solution Prescription INTRAVENOUS AP Apr 5, 2024


10. HAINAN POLY

Hainan Poly Pharm Co Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Hainan Poly.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML) solution Prescription INTRAVENOUS AP Feb 13, 2024


11. INDOCO

Indoco Remedies Ltd has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Indoco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG tablet Prescription ORAL AB Mar 17, 2022
150MG tablet Prescription ORAL AB Mar 17, 2022
100MG tablet Prescription ORAL AB Mar 17, 2022
50MG tablet Prescription ORAL AB Mar 17, 2022
200MG/20ML (10MG/ML) solution Prescription INTRAVENOUS AP Apr 7, 2022


12. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML) solution Prescription INTRAVENOUS AP Jun 29, 2022
200MG tablet Discontinued ORAL N/A Dec 15, 2023
50MG tablet Discontinued ORAL N/A Dec 15, 2023
150MG tablet Discontinued ORAL N/A Dec 15, 2023
100MG tablet Discontinued ORAL N/A Dec 15, 2023


13. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG tablet Discontinued ORAL N/A Jul 12, 2022
200MG tablet Discontinued ORAL N/A Jul 12, 2022
150MG tablet Discontinued ORAL N/A Jul 12, 2022
100MG tablet Discontinued ORAL N/A Jul 12, 2022


14. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML solution Prescription ORAL AA May 15, 2024


15. HETERO LABS LTD V

Hetero Labs Ltd Unit V has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG tablet Prescription ORAL AB Mar 17, 2022
200MG tablet Prescription ORAL AB Mar 17, 2022
50MG tablet Prescription ORAL AB Mar 17, 2022
100MG tablet Prescription ORAL AB Mar 17, 2022


16. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG tablet Prescription ORAL AB Mar 17, 2022
100MG tablet Prescription ORAL AB Mar 17, 2022
200MG tablet Prescription ORAL AB Mar 17, 2022
50MG tablet Prescription ORAL AB Mar 17, 2022


17. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML) solution Prescription INTRAVENOUS AP May 3, 2022


18. LEADING PHARMA

Leading Pharma Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Leading Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML solution Prescription ORAL AA Feb 6, 2023


19. NOVITIUM PHARMA

Novitium Pharma Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Novitium Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML solution Prescription ORAL AA Aug 26, 2022


20. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG tablet Prescription ORAL AB Mar 17, 2022
50MG tablet Prescription ORAL AB Mar 17, 2022
100MG tablet Prescription ORAL AB Mar 17, 2022
150MG tablet Prescription ORAL AB Mar 17, 2022


21. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG tablet Prescription ORAL AB May 24, 2024
150MG tablet Prescription ORAL AB May 24, 2024
100MG tablet Prescription ORAL AB May 24, 2024
50MG tablet Prescription ORAL AB May 24, 2024


22. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG tablet Prescription ORAL AB Apr 28, 2016
200MG tablet Prescription ORAL AB Apr 28, 2016
100MG tablet Prescription ORAL AB Apr 28, 2016
50MG tablet Prescription ORAL AB Apr 28, 2016


23. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML) solution Prescription INTRAVENOUS AP Mar 25, 2024


24. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG tablet Prescription ORAL AB Jan 5, 2023
100MG tablet Prescription ORAL AB Jan 5, 2023
150MG tablet Prescription ORAL AB Jan 5, 2023
200MG tablet Prescription ORAL AB Jan 5, 2023
10MG/ML solution Prescription ORAL AA Jan 24, 2024


25. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG tablet Prescription ORAL AB Mar 17, 2022
200MG tablet Prescription ORAL AB Mar 17, 2022
50MG tablet Prescription ORAL AB Mar 17, 2022
100MG tablet Prescription ORAL AB Mar 17, 2022


26. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG tablet Prescription ORAL AB Mar 31, 2022
100MG tablet Prescription ORAL AB Mar 31, 2022
50MG tablet Prescription ORAL AB Mar 31, 2022
200MG tablet Prescription ORAL AB Mar 31, 2022
10MG/ML solution Prescription ORAL AA May 19, 2022


27. MEDLEY PHARMS

Medley Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Medley Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG tablet Prescription ORAL AB Apr 2, 2024
100MG tablet Prescription ORAL AB Apr 2, 2024
50MG tablet Prescription ORAL AB Apr 2, 2024
200MG tablet Prescription ORAL AB Apr 2, 2024


28. ACTAVIS LABS FL INC

Actavis Laboratories Fl Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet Discontinued ORAL N/A Jan 5, 2023
50MG tablet Discontinued ORAL N/A Jan 5, 2023
150MG tablet Discontinued ORAL N/A Jan 5, 2023
200MG tablet Discontinued ORAL N/A Jan 5, 2023